 | • レポートコード：MRC2307GR359 • 出版社/出版日：GlobalInfoResearch / 2023年7月5日 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の慢性B型肝炎ウイルス検査の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の慢性B型肝炎ウイルス検査市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 慢性B型肝炎ウイルス検査の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 慢性B型肝炎ウイルス検査市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・酵素免疫測定キット、B型肝炎表面抗原検査、抗B型肝炎表面抗体検査、抗B型肝炎コア抗体検査、ポイントオブケア検査キット 用途別セグメント ・病院、診療所、診断センター、自宅 主要な市場プレーヤー ・Gilead Sciences、GlaxoSmithKline、Ionis Pharma、Janssen Sciences Ireland、Assembly Biosciences、Janssen and Arrowhead Pharmaceuticals、Roche、Vir Biotechnology、Bio-Rad Laboratories, Inc.、DiaSorin S.p.A.、Abbott Laboratories、Meridian Bioscience 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、慢性B型肝炎ウイルス検査製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な慢性B型肝炎ウイルス検査メーカーの企業概要、2019年～2022年までの慢性B型肝炎ウイルス検査の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な慢性B型肝炎ウイルス検査メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別慢性B型肝炎ウイルス検査の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの慢性B型肝炎ウイルス検査の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での慢性B型肝炎ウイルス検査市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および慢性B型肝炎ウイルス検査の産業チェーンを掲載しています。 ・第14、15章では、慢性B型肝炎ウイルス検査の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 慢性B型肝炎ウイルス検査の概要 - 種類別分析（2018年vs2022年vs2029年）：酵素免疫測定キット、B型肝炎表面抗原検査、抗B型肝炎表面抗体検査、抗B型肝炎コア抗体検査、ポイントオブケア検査キット - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、診断センター、自宅 - 世界の慢性B型肝炎ウイルス検査市場規模・予測 - 世界の慢性B型肝炎ウイルス検査生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Gilead Sciences、GlaxoSmithKline、Ionis Pharma、Janssen Sciences Ireland、Assembly Biosciences、Janssen and Arrowhead Pharmaceuticals、Roche、Vir Biotechnology、Bio-Rad Laboratories, Inc.、DiaSorin S.p.A.、Abbott Laboratories、Meridian Bioscience ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：酵素免疫測定キット、B型肝炎表面抗原検査、抗B型肝炎表面抗体検査、抗B型肝炎コア抗体検査、ポイントオブケア検査キット ・用途別分析2018年-2029年：病院、診療所、診断センター、自宅 ・慢性B型肝炎ウイルス検査の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・慢性B型肝炎ウイルス検査のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・慢性B型肝炎ウイルス検査のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・慢性B型肝炎ウイルス検査の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・慢性B型肝炎ウイルス検査の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Chronic Hepatitis B Virus Testing market size was valued at USD 884.6 million in 2022 and is forecast to a readjusted size of USD 1384 million by 2029 with a CAGR of 6.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.
This report is a detailed and comprehensive analysis for global Chronic Hepatitis B Virus Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chronic Hepatitis B Virus Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chronic Hepatitis B Virus Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chronic Hepatitis B Virus Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chronic Hepatitis B Virus Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Hepatitis B Virus Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Hepatitis B Virus Testing market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland and Assembly Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Chronic Hepatitis B Virus Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Enzyme Immunoassay Kits
Hepatitis B Surface Antigen Test
Anti-Hepatitis B Surface Antibody Test
Anti-Hepatitis B Core Antibody Test
Point-of-Care Testing Kits
Market segment by Application
Hospitals
Clinics
Diagnostic Centers
Home
Major players covered
Gilead Sciences
GlaxoSmithKline
Ionis Pharma
Janssen Sciences Ireland
Assembly Biosciences
Janssen and Arrowhead Pharmaceuticals
Roche
Vir Biotechnology
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A.
Abbott Laboratories
Meridian Bioscience
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Hepatitis B Virus Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Hepatitis B Virus Testing, with price, sales, revenue and global market share of Chronic Hepatitis B Virus Testing from 2018 to 2023.
Chapter 3, the Chronic Hepatitis B Virus Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Hepatitis B Virus Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Chronic Hepatitis B Virus Testing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Hepatitis B Virus Testing.
Chapter 14 and 15, to describe Chronic Hepatitis B Virus Testing sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Chronic Hepatitis B Virus Testing
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chronic Hepatitis B Virus Testing Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Enzyme Immunoassay Kits
1.3.3 Hepatitis B Surface Antigen Test
1.3.4 Anti-Hepatitis B Surface Antibody Test
1.3.5 Anti-Hepatitis B Core Antibody Test
1.3.6 Point-of-Care Testing Kits
1.4 Market Analysis by Application
1.4.1 Overview: Global Chronic Hepatitis B Virus Testing Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Diagnostic Centers
1.4.5 Home
1.5 Global Chronic Hepatitis B Virus Testing Market Size & Forecast
1.5.1 Global Chronic Hepatitis B Virus Testing Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Chronic Hepatitis B Virus Testing Sales Quantity (2018-2029)
1.5.3 Global Chronic Hepatitis B Virus Testing Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Chronic Hepatitis B Virus Testing Product and Services
2.1.4 Gilead Sciences Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Gilead Sciences Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Chronic Hepatitis B Virus Testing Product and Services
2.2.4 GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Ionis Pharma
2.3.1 Ionis Pharma Details
2.3.2 Ionis Pharma Major Business
2.3.3 Ionis Pharma Chronic Hepatitis B Virus Testing Product and Services
2.3.4 Ionis Pharma Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ionis Pharma Recent Developments/Updates
2.4 Janssen Sciences Ireland
2.4.1 Janssen Sciences Ireland Details
2.4.2 Janssen Sciences Ireland Major Business
2.4.3 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product and Services
2.4.4 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Janssen Sciences Ireland Recent Developments/Updates
2.5 Assembly Biosciences
2.5.1 Assembly Biosciences Details
2.5.2 Assembly Biosciences Major Business
2.5.3 Assembly Biosciences Chronic Hepatitis B Virus Testing Product and Services
2.5.4 Assembly Biosciences Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Assembly Biosciences Recent Developments/Updates
2.6 Janssen and Arrowhead Pharmaceuticals
2.6.1 Janssen and Arrowhead Pharmaceuticals Details
2.6.2 Janssen and Arrowhead Pharmaceuticals Major Business
2.6.3 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product and Services
2.6.4 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Janssen and Arrowhead Pharmaceuticals Recent Developments/Updates
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Chronic Hepatitis B Virus Testing Product and Services
2.7.4 Roche Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roche Recent Developments/Updates
2.8 Vir Biotechnology
2.8.1 Vir Biotechnology Details
2.8.2 Vir Biotechnology Major Business
2.8.3 Vir Biotechnology Chronic Hepatitis B Virus Testing Product and Services
2.8.4 Vir Biotechnology Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vir Biotechnology Recent Developments/Updates
2.9 Bio-Rad Laboratories, Inc.
2.9.1 Bio-Rad Laboratories, Inc. Details
2.9.2 Bio-Rad Laboratories, Inc. Major Business
2.9.3 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product and Services
2.9.4 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
2.10 DiaSorin S.p.A.
2.10.1 DiaSorin S.p.A. Details
2.10.2 DiaSorin S.p.A. Major Business
2.10.3 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product and Services
2.10.4 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 DiaSorin S.p.A. Recent Developments/Updates
2.11 Abbott Laboratories
2.11.1 Abbott Laboratories Details
2.11.2 Abbott Laboratories Major Business
2.11.3 Abbott Laboratories Chronic Hepatitis B Virus Testing Product and Services
2.11.4 Abbott Laboratories Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Abbott Laboratories Recent Developments/Updates
2.12 Meridian Bioscience
2.12.1 Meridian Bioscience Details
2.12.2 Meridian Bioscience Major Business
2.12.3 Meridian Bioscience Chronic Hepatitis B Virus Testing Product and Services
2.12.4 Meridian Bioscience Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Meridian Bioscience Recent Developments/Updates
3 Competitive Environment: Chronic Hepatitis B Virus Testing by Manufacturer
3.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Manufacturer (2018-2023)
3.2 Global Chronic Hepatitis B Virus Testing Revenue by Manufacturer (2018-2023)
3.3 Global Chronic Hepatitis B Virus Testing Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Chronic Hepatitis B Virus Testing by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Chronic Hepatitis B Virus Testing Manufacturer Market Share in 2022
3.4.2 Top 6 Chronic Hepatitis B Virus Testing Manufacturer Market Share in 2022
3.5 Chronic Hepatitis B Virus Testing Market: Overall Company Footprint Analysis
3.5.1 Chronic Hepatitis B Virus Testing Market: Region Footprint
3.5.2 Chronic Hepatitis B Virus Testing Market: Company Product Type Footprint
3.5.3 Chronic Hepatitis B Virus Testing Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Chronic Hepatitis B Virus Testing Market Size by Region
4.1.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Region (2018-2029)
4.1.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Region (2018-2029)
4.1.3 Global Chronic Hepatitis B Virus Testing Average Price by Region (2018-2029)
4.2 North America Chronic Hepatitis B Virus Testing Consumption Value (2018-2029)
4.3 Europe Chronic Hepatitis B Virus Testing Consumption Value (2018-2029)
4.4 Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value (2018-2029)
4.5 South America Chronic Hepatitis B Virus Testing Consumption Value (2018-2029)
4.6 Middle East and Africa Chronic Hepatitis B Virus Testing Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
5.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Type (2018-2029)
5.3 Global Chronic Hepatitis B Virus Testing Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
6.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Application (2018-2029)
6.3 Global Chronic Hepatitis B Virus Testing Average Price by Application (2018-2029)
7 North America
7.1 North America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
7.2 North America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
7.3 North America Chronic Hepatitis B Virus Testing Market Size by Country
7.3.1 North America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2029)
7.3.2 North America Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
8.2 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
8.3 Europe Chronic Hepatitis B Virus Testing Market Size by Country
8.3.1 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2029)
8.3.2 Europe Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Chronic Hepatitis B Virus Testing Market Size by Region
9.3.1 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
10.2 South America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
10.3 South America Chronic Hepatitis B Virus Testing Market Size by Country
10.3.1 South America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2029)
10.3.2 South America Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Chronic Hepatitis B Virus Testing Market Size by Country
11.3.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Chronic Hepatitis B Virus Testing Market Drivers
12.2 Chronic Hepatitis B Virus Testing Market Restraints
12.3 Chronic Hepatitis B Virus Testing Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Chronic Hepatitis B Virus Testing and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chronic Hepatitis B Virus Testing
13.3 Chronic Hepatitis B Virus Testing Production Process
13.4 Chronic Hepatitis B Virus Testing Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chronic Hepatitis B Virus Testing Typical Distributors
14.3 Chronic Hepatitis B Virus Testing Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Chronic Hepatitis B Virus Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Chronic Hepatitis B Virus Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Chronic Hepatitis B Virus Testing Product and Services
Table 6. Gilead Sciences Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Gilead Sciences Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Chronic Hepatitis B Virus Testing Product and Services
Table 11. GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Ionis Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Ionis Pharma Major Business
Table 15. Ionis Pharma Chronic Hepatitis B Virus Testing Product and Services
Table 16. Ionis Pharma Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Ionis Pharma Recent Developments/Updates
Table 18. Janssen Sciences Ireland Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Sciences Ireland Major Business
Table 20. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product and Services
Table 21. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Janssen Sciences Ireland Recent Developments/Updates
Table 23. Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table 24. Assembly Biosciences Major Business
Table 25. Assembly Biosciences Chronic Hepatitis B Virus Testing Product and Services
Table 26. Assembly Biosciences Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Assembly Biosciences Recent Developments/Updates
Table 28. Janssen and Arrowhead Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Janssen and Arrowhead Pharmaceuticals Major Business
Table 30. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product and Services
Table 31. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Janssen and Arrowhead Pharmaceuticals Recent Developments/Updates
Table 33. Roche Basic Information, Manufacturing Base and Competitors
Table 34. Roche Major Business
Table 35. Roche Chronic Hepatitis B Virus Testing Product and Services
Table 36. Roche Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Roche Recent Developments/Updates
Table 38. Vir Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Vir Biotechnology Major Business
Table 40. Vir Biotechnology Chronic Hepatitis B Virus Testing Product and Services
Table 41. Vir Biotechnology Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vir Biotechnology Recent Developments/Updates
Table 43. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Bio-Rad Laboratories, Inc. Major Business
Table 45. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product and Services
Table 46. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 48. DiaSorin S.p.A. Basic Information, Manufacturing Base and Competitors
Table 49. DiaSorin S.p.A. Major Business
Table 50. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product and Services
Table 51. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. DiaSorin S.p.A. Recent Developments/Updates
Table 53. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Laboratories Major Business
Table 55. Abbott Laboratories Chronic Hepatitis B Virus Testing Product and Services
Table 56. Abbott Laboratories Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Abbott Laboratories Recent Developments/Updates
Table 58. Meridian Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. Meridian Bioscience Major Business
Table 60. Meridian Bioscience Chronic Hepatitis B Virus Testing Product and Services
Table 61. Meridian Bioscience Chronic Hepatitis B Virus Testing Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Meridian Bioscience Recent Developments/Updates
Table 63. Global Chronic Hepatitis B Virus Testing Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Chronic Hepatitis B Virus Testing Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Chronic Hepatitis B Virus Testing Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Chronic Hepatitis B Virus Testing, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Chronic Hepatitis B Virus Testing Production Site of Key Manufacturer
Table 68. Chronic Hepatitis B Virus Testing Market: Company Product Type Footprint
Table 69. Chronic Hepatitis B Virus Testing Market: Company Product Application Footprint
Table 70. Chronic Hepatitis B Virus Testing New Market Entrants and Barriers to Market Entry
Table 71. Chronic Hepatitis B Virus Testing Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Chronic Hepatitis B Virus Testing Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Chronic Hepatitis B Virus Testing Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Chronic Hepatitis B Virus Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Chronic Hepatitis B Virus Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Chronic Hepatitis B Virus Testing Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Chronic Hepatitis B Virus Testing Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Chronic Hepatitis B Virus Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Chronic Hepatitis B Virus Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Chronic Hepatitis B Virus Testing Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Chronic Hepatitis B Virus Testing Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Chronic Hepatitis B Virus Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Chronic Hepatitis B Virus Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Chronic Hepatitis B Virus Testing Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Chronic Hepatitis B Virus Testing Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Chronic Hepatitis B Virus Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Chronic Hepatitis B Virus Testing Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Chronic Hepatitis B Virus Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Chronic Hepatitis B Virus Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Chronic Hepatitis B Virus Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Chronic Hepatitis B Virus Testing Raw Material
Table 131. Key Manufacturers of Chronic Hepatitis B Virus Testing Raw Materials
Table 132. Chronic Hepatitis B Virus Testing Typical Distributors
Table 133. Chronic Hepatitis B Virus Testing Typical Customers
List of Figures
Figure 1. Chronic Hepatitis B Virus Testing Picture
Figure 2. Global Chronic Hepatitis B Virus Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Type in 2022
Figure 4. Enzyme Immunoassay Kits Examples
Figure 5. Hepatitis B Surface Antigen Test Examples
Figure 6. Anti-Hepatitis B Surface Antibody Test Examples
Figure 7. Anti-Hepatitis B Core Antibody Test Examples
Figure 8. Point-of-Care Testing Kits Examples
Figure 9. Global Chronic Hepatitis B Virus Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Clinics Examples
Figure 13. Diagnostic Centers Examples
Figure 14. Home Examples
Figure 15. Global Chronic Hepatitis B Virus Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Chronic Hepatitis B Virus Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Chronic Hepatitis B Virus Testing Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Chronic Hepatitis B Virus Testing Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Chronic Hepatitis B Virus Testing by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Chronic Hepatitis B Virus Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Chronic Hepatitis B Virus Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Chronic Hepatitis B Virus Testing Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Chronic Hepatitis B Virus Testing Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Chronic Hepatitis B Virus Testing Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Chronic Hepatitis B Virus Testing Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Chronic Hepatitis B Virus Testing Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Chronic Hepatitis B Virus Testing Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Chronic Hepatitis B Virus Testing Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Chronic Hepatitis B Virus Testing Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value Market Share by Region (2018-2029)
Figure 57. China Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Chronic Hepatitis B Virus Testing Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Chronic Hepatitis B Virus Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Chronic Hepatitis B Virus Testing Market Drivers
Figure 78. Chronic Hepatitis B Virus Testing Market Restraints
Figure 79. Chronic Hepatitis B Virus Testing Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Chronic Hepatitis B Virus Testing in 2022
Figure 82. Manufacturing Process Analysis of Chronic Hepatitis B Virus Testing
Figure 83. Chronic Hepatitis B Virus Testing Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
